FLPUTNAM INVESTMENT MANAGEMENT CO
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1140334
PORTLAND, ME
Position in VRTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$17,637,436
+$957,869 QoQ
Shares Held
39,498
+7.4% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 57.4662008202947.ToString("F0")%
Shared 0.ToString("F0")%
None 42.5337991797053.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $37,680,376 across 10 Biotechnology names. VRTX ranks #1 (46.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
39,498 | $17,637,436 | |
| 2 | TRVI |
Trevi Therapeutics, Inc.
|
1,063,301 | $12,685,180 | |
| 3 | ZVRA |
Zevra Therapeutics, Inc.
|
350,501 | $3,266,669 | |
| 4 | KZIA |
Kazia Therapeutics Ltd
|
142,469 | $1,059,969 | |
| 5 | CRDF |
Cardiff Oncology, Inc.
|
595,127 | $964,105 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,741 | $906,914 | |
| 7 | GNLX |
GENELUX Corp
|
280,904 | $679,787 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
454 | $350,778 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,637,436 | 39,498 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $16,679,567 | 36,791 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $13,580,508 | 34,676 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $16,802,293 | 37,741 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,693,990 | 36,496 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,662,096 | 31,443 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,326,174 | 9,302 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $802,917 | 1,713 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $604,442 | 1,446 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $561,508 | 1,380 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $474,317 | 1,364 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $476,486 | 1,354 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $379,659 | 1,205 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $311,016 | 1,077 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $268,403 | 927 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $268,545 | 953 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $250,531 | 960 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $205,765 | 937 | Shares | Sole | 2022-02-15 | |
| 2021-03-31 | $203,930 | 949 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $239,176 | 1,012 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $280,011 | 1,029 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $298,728 | 1,029 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $244,612 | 1,028 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||